공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 과민성 대장 증후군(IBS) 시장(2017-2022년)

Global Irritable Bowel Syndrome (IBS) Research Report 2017-2022

리서치사 QYResearch
발행일 2017년 12월 상품 코드 599296
페이지 정보 영문
가격
US $ 2,900 ₩ 3,301,000 PDF (Single User License)
US $ 5,800 ₩ 6,602,000 PDF (Enterprise Wide License)


세계의 과민성 대장 증후군(IBS) 시장(2017-2022년) Global Irritable Bowel Syndrome (IBS) Research Report 2017-2022
발행일 : 2017년 12월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 과민성 대장 증후군(IBS : Irritable Bowel Syndrome) 시장에 대해 조사했으며, 시장 개요와 제품별, 종류별, 용도별 및 지역별 동향, 시장에 참여하는 기업 개요 등의 정보를 전해드립니다.

제1장 시장 개요

  • 제품 개요와 범위
  • 종류별 부문
  • 용도별 부문
  • 지역별 시장
  • 시장 규모

제2장 제조업체별 시장 경쟁

  • 제조업체별 매출과 시장 점유율
  • 제조업체별 총이익
  • 제조업체의 본사, 판매 영역, 제품 종류
  • 시장 경쟁 상황 및 동향
    • 시장 집중률
    • 상위 3개, 5개 제조업체의 매출 시장 점유율
    • 합병, 인수, 확충

제3장 지역별 매출

  • 지역별 매출
  • 세계 시장 매출과 총이익
  • 북미
  • 유럽
  • 일본
  • 기타 국가

제4장 종류별 매출 규모

  • 매출과 시장 점유율
  • 성장률

제5장 용도별 시장 분석

  • 판매와 시장 점유율
  • 판매 성장률

제6장 제조업체 개요/분석

  • Allergan
  • Valeant Pharmaceuticals
  • Takeda
  • Sucampo Pharmaceuticals
  • McNeil Consumer Healthcare
  • Sebela Pharmaceuticals
  • Astellas Pharmaceuticals
  • IM HealthScience

제7장 제조 비용 분석

  • 연구 개발 비용 분석
  • 제조 비용 구조 비율

제8장 업계 체인, 조달 전략, 다운스트림 바이어

제9장 마케팅 전략 분석, 판매업체/무역업체

  • 마케팅 채널
  • 시장 포지셔닝
  • 판매업체/무역업체 리스트

제10장 시장 영향요인 분석

  • 과민성 대장 증후군의 실태와 동향
  • 소비자 요구/소비자 기호의 변화
  • 경제적/정치적 환경의 변화

제11장 시장 예측

  • 매출 예측
  • 지역별 매출 예측
  • 종류별 매출 예측
  • 용도별 매출 예측

제12장 조사 결과와 결론

제13장 조사 방법과 정보 출처

KSM 18.01.11

This report studies the Irritable Bowel Syndrome market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Irritable Bowel Syndrome market by product type and applications/end industries.

The major players in global Irritable Bowel Syndrome market include

Allergan

Valeant Pharmaceuticals

Takeda

Sucampo Pharmaceuticals

McNeil Consumer Healthcare

Sebela Pharmaceuticals

Astellas Pharmaceuticals

IM HealthScience

Geographically, this report is segmented into several key Regions, with revenue, market share and growth rate of Irritable Bowel Syndrome in these regions, from 2012 to 2022 (forecast), covering

North America

Europe

Japan

RoW

On the basis of product, the Irritable Bowel Syndrome market is primarily split into

IBS-D Drug

IBS-C Drug

Other

On the basis on the end users/applications, this report covers

Women

Men

Table of Contents

1 Irritable Bowel Syndrome Market Overview 1

  • 1.1 Product Overview and Scope of Irritable Bowel Syndrome 1
  • 1.2 Irritable Bowel Syndrome Segment by Types (Product Category) 2
    • 1.2.1 Global Irritable Bowel Syndrome Revenue and Growth Rate (%) Comparison by Types (Product Category) (2016-2022) 2
    • 1.2.2 Global Irritable Bowel Syndrome Market Share (%) by Types (Product Category) in 2016 3
    • 1.2.3 IBS-D Drug 4
    • 1.2.4 IBS-C Drug 4
    • 1.2.5 Other 5
  • 1.3 Global Irritable Bowel Syndrome Segment by Applications 5
    • 1.3.1 Global Irritable Bowel Syndrome Sales Comparison by Applications (2012-2022) 5
    • 1.3.2 Women 7
    • 1.3.3 Men 7
  • 1.4 Global Irritable Bowel Syndrome Market by Regions (2012-2022) 8
    • 1.4.1 Global Irritable Bowel Syndrome Market Size (M USD) Comparison by Regions (2012-2022) 8
    • 1.4.2 North America Irritable Bowel Syndrome Status and Prospect (2012-2022) 9
    • 1.4.3 Japan Irritable Bowel Syndrome Status and Prospect (2012-2022) 10
    • 1.4.4 Europe Irritable Bowel Syndrome Status and Prospect (2012-2022) 11
    • 1.4.5 RoW Irritable Bowel Syndrome Status and Prospect (2012-2022) 12
  • 1.5 Global Irritable Bowel Syndrome Market Size (2012-2022) 13

2 Global Irritable Bowel Syndrome Market Competition by Manufacturers 14

  • 2.1 Global Irritable Bowel Syndrome Revenue and Market Share by Manufacturers (2016-2017) 14
  • 2.2 Global Irritable Bowel Syndrome Gross Margin by Manufacturers (2016-2017) 16
  • 2.3 Manufacturers Irritable Bowel Syndrome Headquarter, Sales Area, Product Types 17
  • 2.4 Irritable Bowel Syndrome Market Competitive Situation and Trends 19
    • 2.4.1 Irritable Bowel Syndrome Market Concentration Rate 19
    • 2.4.2 Irritable Bowel Syndrome Revenue Market Share (%) of Top 3 and Top 5 Manufacturers in 2016 20
    • 2.4.3 Mergers & Acquisitions, Expansion 21

3 Global Irritable Bowel Syndrome Revenue by Regions (2012-2017) 23

  • 3.1 Global Irritable Bowel Syndrome Revenue and Market Share (%) by Regions (2012-2017) 23
  • 3.2 Global Irritable Bowel Syndrome Revenue and Gross Margin (%) (2012-2017) 26
  • 3.3 North America Irritable Bowel Syndrome Revenue and Gross Margin (%) (2012-2017) 27
  • 3.4 Europe Irritable Bowel Syndrome Revenue, Price and Gross Margin (2012-2017) 27
  • 3.5 Japan Irritable Bowel Syndrome Revenue, Price and Gross Margin (2012-2017) 27
  • 3.6 RoW Irritable Bowel Syndrome Revenue, Price and Gross Margin (2012-2017) 28

4 Global Irritable Bowel Syndrome Revenue Size by Types 29

  • 4.1 Global Irritable Bowel Syndrome Revenue and Market Share by Types (2012-2017) 29
  • 4.2 Global Irritable Bowel Syndrome Growth by Type (2012-2017) 31

5 Global Irritable Bowel Syndrome Market Analysis by Applications 32

  • 5.1 Global Irritable Bowel Syndrome Sales and Market Share by Applications (2012-2017) 32
  • 5.2 Global Irritable Bowel Syndrome Sales Growth Rate by Applications (2012-2017) 34

6 Global Irritable Bowel Syndrome Manufacturers Profiles/Analysis 35

  • 6.1 Allergan 35
    • 6.1.1 Company Basic Information, Key Products and Sales Area 35
    • 6.1.2 Irritable Bowel Syndrome Product Category, Application and Specification 36
    • 6.1.3 Allergan Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017) 37
  • 6.2 Valeant Pharmaceuticals 38
    • 6.2.1 Company Basic Information, Key Products and Sales Area 38
    • 6.2.2 Irritable Bowel Syndrome Product Category, Application and Specification 39
    • 6.2.3 Valeant Pharmaceuticals Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017) 40
  • 6.3 Takeda 40
    • 6.3.1 Company Basic Information, Key Products and Sales Area 40
    • 6.3.2 Irritable Bowel Syndrome Product Category, Application and Specification 41
    • 6.3.3 Takeda Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017) 42
  • 6.4 Sucampo Pharmaceuticals 42
    • 6.4.1 Company Basic Information, Key Products and Sales Area 42
    • 6.4.2 Irritable Bowel Syndrome Product Category, Application and Specification 43
    • 6.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017) 44
  • 6.5 McNeil Consumer Healthcare 45
    • 6.5.1 Company Basic Information, Key Products and Sales Area 45
    • 6.5.2 Irritable Bowel Syndrome Product Category, Application and Specification 46
    • 6.5.3 McNeil Consumer Healthcare Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017) 46
  • 6.6 Sebela Pharmaceuticals 47
    • 6.6.1 Company Basic Information, Key Products and Sales Area 47
    • 6.6.2 Irritable Bowel Syndrome Product Category, Application and Specification 48
    • 6.6.3 Sebela Pharmaceuticals Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017) 48
  • 6.7 Astellas Pharmaceuticals 49
    • 6.7.1 Company Basic Information, Key Products and Sales Area 49
    • 6.7.2 Irritable Bowel Syndrome Product Category, Application and Specification 50
    • 6.7.3 Astellas Pharmaceuticals Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017) 51
  • 6.8 IM HealthScience 51
    • 6.8.1 Company Basic Information, Key Products and Sales Area 51
    • 6.8.2 Irritable Bowel Syndrome Product Category, Application and Specification 52
    • 6.8.3 IM HealthScience Irritable Bowel Syndrome Revenue and Gross Margin (2016-2017) 53

7 Irritable Bowel Syndrome Manufacturing Cost Analysis 54

  • 7.1 Irritable Bowel Syndrome R&D Cost Analysis 54
    • 7.1.1 Clinical Phase Costs 55
    • 7.1.2 Capitalized Costs 56
    • 7.1.3 United States Irritable Bowel Syndrome Medical Cost 57
  • 7.2 Proportion of Manufacturing Cost Structure 57
    • 7.2.1 Raw Materials 58
    • 7.2.2 Labor Cost 58
    • 7.2.3 Manufacturing Expenses 63

8 Industrial Chain, Sourcing Strategy and Downstream Buyers 69

  • 8.1 Irritable Bowel Syndrome Industrial Chain Analysis 69
  • 8.2 Upstream Raw Materials Sourcing 69
  • 8.3 Downstream Buyers 70

9 Marketing Strategy Analysis, Distributors/Traders 71

  • 9.1 Marketing Channel 71
    • 9.1.1 Direct Marketing 71
    • 9.1.2 Indirect Marketing 71
    • 9.1.3 Marketing Channel Development Trend 71
  • 9.2 Market Positioning 72
    • 9.2.1 Pricing Strategy 72
    • 9.2.2 Brand Strategy 73
  • 9.3 Distributors/Traders List 74

10 Market Effect Factors Analysis 75

  • 10.1 Irritable Bowel Syndrome Facts and Dynamic 75
    • 10.1.1 FDA Approves Two Therapies to Treat IBS-D in 2015 75
    • 10.1.2 Irritable Bowel Syndrome Facts 76
  • 10.2 Consumer Needs/Customer Preference Change 78
  • 10.3 Economic/Political Environmental Change 79

11 Global Irritable Bowel Syndrome Market Forecast (2017-2022) 87

  • 11.1 Global Irritable Bowel Syndrome Sales Revenue (M USD) Forecast (2017-2022) 87
  • 11.2 Global Irritable Bowel Syndrome Revenue (M USD) Forecast by Regions (2017-2022) 87
    • 11.2.1 North America Irritable Bowel Syndrome Revenue (M USD) Forecast (2017-2022) 89
    • 11.2.2 Europe Irritable Bowel Syndrome Revenue (M USD) Forecast (2017-2022) 90
    • 11.2.3 Japan Irritable Bowel Syndrome Revenue (M USD) Forecast (2017-2022) 91
    • 11.2.4 RoW Irritable Bowel Syndrome Revenue (M USD) Forecast (2017-2022) 92
  • 11.3 Global Irritable Bowel Syndrome Sales Revenue (M USD) Forecast by Type (2017-2022) 92
  • 11.4 Global Irritable Bowel Syndrome Revenue Forecast by Application (2017-2022) 94

12 Research Findings and Conclusion 96

13 Methodology and Data Source 97

  • 13.1 Methodology/Research Approach 97
    • 13.1.1 Research Programs/Design 97
    • 13.1.2 Market Size Estimation 98
    • 13.1.3 Market Breakdown and Data Triangulation 99
  • 13.2 Data Source 100
    • 13.2.1 Secondary Sources 100
    • 13.2.2 Primary Sources 101
  • 13.3 Disclaimer 102
  • 13.4 Author List 103

List of Tables and Figures

  • Figure Product Picture of Irritable Bowel Syndrome 1
  • Table Global Irritable Bowel Syndrome Revenue and Growth Rate (%) Comparison by Types (2016-2022) 2
  • Figure Global Irritable Bowel Syndrome Revenue Market Share (%) by Types (Product Category) in 2016 3
  • Table Irritable Bowel Syndrome Type and Characteristic 3
  • Figure Product Picture of IBS-D Drug 4
  • Figure Product Picture of IBS-C Drug 4
  • Figure Product Picture of Other 5
  • Table Global Irritable Bowel Syndrome Sales Comparison by Applications (2012-2022) 5
  • Figure Global Irritable Bowel Syndrome Sales Market Share (%) by Applications in 2016 6
  • Table IBS Symptoms in Men and Women 6
  • Figure Women Examples 7
  • Figure Men Examples 7
  • Figure Global Irritable Bowel Syndrome Market Size (M USD) Comparison by Regions (2012-2022) 8
  • Figure North America Irritable Bowel Syndrome Revenue (M USD) and Growth Rate (%) (2012-2022) 9
  • Figure Japan Irritable Bowel Syndrome Revenue (M USD) and Growth Rate (%) (2012-2022) 10
  • Figure Europe Irritable Bowel Syndrome Revenue (M USD) and Growth Rate (%) (2012-2022) 11
  • Figure RoW Irritable Bowel Syndrome Revenue (M USD) and Growth Rate (%) (2012-2022) 12
  • Figure Global Irritable Bowel Syndrome Revenue (M USD) Status and Outlook (2012-2022) 13
  • Table Global Irritable Bowel Syndrome Revenue (M USD) by Manufacturers (2016-2017) 14
  • Table Global Irritable Bowel Syndrome Revenue Share (%) by Manufacturers (2016-2017) 14
  • Figure 2016 Global Irritable Bowel Syndrome Revenue Share (%) by Manufacturers 15
  • Figure 2017 Global Irritable Bowel Syndrome Revenue Share (%) by Manufacturers 16
  • Table Global Market Irritable Bowel Syndrome Gross Margin) of Key Manufacturers (2016-2017) 16
  • Figure Global Market Irritable Bowel Syndrome Gross Margin of Key Manufacturers in 2016 17
  • Table Manufacturers Irritable Bowel Syndrome Headquarter and Sales Area 17
  • Table Manufacturers Irritable Bowel Syndrome Product Category 18
  • Figure Irritable Bowel Syndrome Market Concentration Rate in 2016 19
  • Figure Irritable Bowel Syndrome Revenue Market Share (%) of Top 3 Manufacturers in 2016 20
  • Figure Irritable Bowel Syndrome Revenue Market Share (%) of Top 5 Manufacturers in 2016 20
  • Table Mergers & Acquisitions, Expansion News 21
  • Table Global Irritable Bowel Syndrome Revenue (M USD) by Regions (2012-2017) 23
  • Table Global Irritable Bowel Syndrome Revenue Market Share (%) by Regions (2012-2017) 23
  • Figure Global Irritable Bowel Syndrome Revenue Market Share (%) by Regions (2012-2017) 24
  • Figure 2016 Global Irritable Bowel Syndrome Revenue Market Share (%) by Regions 24
  • Figure 2017 Global Irritable Bowel Syndrome Revenue Market Share (%) by Regions 25
  • Figure Global Irritable Bowel Syndrome Revenue and Growth Rate (%) (2012-2017) 26
  • Table Global Irritable Bowel Syndrome Revenue (M USD) and Gross Margin (%) (2012-2017) 26
  • Table North America Irritable Bowel Syndrome Revenue (M USD) and Gross Margin (%) (2012-2017) 27
  • Table Europe Irritable Bowel Syndrome Revenue (M USD) and Gross Margin (%) (2012-2017) 27
  • Table Japan Irritable Bowel Syndrome Revenue (M USD) and Gross Margin (%) (2012-2017) 27
  • Table RoW Irritable Bowel Syndrome Revenue (M USD) and Gross Margin (%) (2012-2017) 28
  • Table Global Irritable Bowel Syndrome Revenue (M USD) by Types (2012-2017) 29
  • Table Global Irritable Bowel Syndrome Revenue Share (%) by Types (2012-2017) 29
  • Figure Revenue Share (%) Irritable Bowel Syndrome by Types (2012-2017) 30
  • Figure 2016 Revenue Market Share (%) of Irritable Bowel Syndrome by Types 30
  • Table Global Irritable Bowel Syndrome Growth by Type (2012-2017) 31
  • Figure Global Irritable Bowel Syndrome Growth by Type (2012-2017) 31
  • Table Global Irritable Bowel Syndrome Sales by Applications (2012-2017) 32
  • Table Global Irritable Bowel Syndrome Sales Market Share (%) by Applications (2012-2017) 32
  • Figure Global Irritable Bowel Syndrome Sales Market Share (%) by Applications (2012-2017) 33
  • Figure Global Irritable Bowel Syndrome Sales Market Share (%) by Applications in 2016 33
  • Table Global Irritable Bowel Syndrome Sales Growth Rate (%) by Applications (2012-2017) 34
  • Figure Global Irritable Bowel Syndrome Sales Growth Rate (%) by Applications (2012-2017) 34
  • Table Allergan Basic Information, Key Products and Sales Area 35
  • Table Irritable Bowel Syndrome Product Category, Application and Specification 36
  • Table Allergan Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017) 37
  • Table Valeant Pharmaceuticals Basic Information, Key Products and Sales Area 38
  • Table Irritable Bowel Syndrome Product Category, Application and Specification 39
  • Table Valeant Pharmaceuticals Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017) 40
  • Table Takeda Basic Information, Key Products and Sales Area 40
  • Table Irritable Bowel Syndrome Product Category, Application and Specification 41
  • Table Takeda Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017) 42
  • Table Sucampo Pharmaceuticals Basic Information, Key Products and Sales Area 42
  • Table Irritable Bowel Syndrome Product Category, Application and Specification 43
  • Table Sucampo Pharmaceuticals Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017) 44
  • Table McNeil Consumer Healthcare Basic Information, Key Products and Sales Area 45
  • Table Irritable Bowel Syndrome Product Category, Application and Specification 46
  • Table McNeil Consumer Healthcare Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017) 46
  • Table Sebela Pharmaceuticals Basic Information, Key Products and Sales Area 47
  • Table Irritable Bowel Syndrome Product Category, Application and Specification 48
  • Table Sebela Pharmaceuticals Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017) 48
  • Table Astellas Pharmaceuticals Basic Information, Key Products and Sales Area 49
  • Table Irritable Bowel Syndrome Product Category, Application and Specification 50
  • Table Astellas Pharmaceuticals Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017) 51
  • Table IM HealthScience Basic Information, Key Products and Sales Area 51
  • Table Irritable Bowel Syndrome Product Category, Application and Specification 52
  • Table IM HealthScience Irritable Bowel Syndrome Revenue (M USD), and Gross Margin (%) (2016-2017) 53
  • Figure Typical Phases from Research to the Market for a Drug Candidate 55
  • Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Irritable Bowel Syndrome Compound 56
  • Table Capitalized Preclinical and Clinical Period Costs per Investigational Irritable Bowel Syndrome Compound 57
  • Table Manufacturing Cost Structure of Irritable Bowel Syndrome 57
  • Figure 2016 Manufacturing Labor Cost Per Hour in China as a Proportion of Those in Other Countries (%) 59
  • Figure Manufacturing Labor Costs in Select Provinces and Countries in 2016 59
  • Figure 2016 Global Manufacturing Competitiveness Index rankings by country 60
  • Figure US Nonfarm Unit Labor Cost 2014-2016 61
  • Figure USA Average Hourly Wages (USD/H) 2016-2017 61
  • Figure China Labor Cost Index 2014-2016 62
  • Figure China Average Yearly Wages 2006-2016 62
  • Figure Euro Area Labor Cost 2014-2016 63
  • Table Gross Margin of Electricity to Ultimate Customers 2007-2016 63
  • Figure Electricity Prices for Household Consumers in 2016 65
  • Figure Summary of the Driving Assumptions 66
  • Figure Industrial Electric Rates 2016 (PER KWH) 67
  • Figure Irritable Bowel Syndrome Industrial Chain Analysis 69
  • Table Major Buyers of Irritable Bowel Syndrome 70
  • Figure Setting Pricing Policy 72
  • Table Distributors/Traders List 74
  • Figure IBS Causes, Changes, Triggers and Symptoms 78
  • Figure Global GDP Growth Rate for 2016 79
  • Figure US GDP 2006-2016 (Billion USD) 80
  • Figure US CPI Change 2016-2017 80
  • Figure EU GDP 2006-2016 (Billion USD) 81
  • Figure EU CPI Change 2012-2016 81
  • Figure Germany GDP 2006-2016 (Billion USD) 82
  • Figure UK GDP 2006-2016 (Billion USD) 82
  • Figure UK CPI Change 2016-2017 83
  • Figure Italy GDP 2006-2016 (Billion USD) 83
  • Figure Italy CPI Change 2016-2017 84
  • Figure Japan CPI Change 2012-2016 84
  • Figure Japan GDP 2006-2016 (Billion USD) 85
  • Figure China GDP 2006-2016 (Billion USD) 85
  • Figure China CPI Change 2016-2017 86
  • Figure Global Irritable Bowel Syndrome Revenue (M USD) and Growth Rate (%) Forecast (2017-2022) 87
  • Table Global Irritable Bowel Syndrome Revenue (M USD) Forecast by Regions (2017-2022) 87
  • Figure Global Irritable Bowel Syndrome Sales Market Share (%) Forecast by Regions (2017-2022) 88
  • Figure North America Irritable Bowel Syndrome Revenue and Growth Rate (%) Forecast (2017-2022) 89
  • Figure Europe Irritable Bowel Syndrome Revenue and Growth Rate (%) Forecast (2017-2022) 90
  • Figure Japan Irritable Bowel Syndrome Revenue and Growth Rate (%) Forecast (2017-2022) 91
  • Figure RoW Irritable Bowel Syndrome Revenue and Growth Rate (%) Forecast (2017-2022) 92
  • Table Global Irritable Bowel Syndrome Revenue (M USD) Forecast by Type (2017-2022) 92
  • Table Global Irritable Bowel Syndrome Revenue Share Forecast by Type (2017-2022) 93
  • Figure Global Irritable Bowel Syndrome Revenue Market Share (%) Forecast by Type (2017-2022) 93
  • Figure Global Irritable Bowel Syndrome Revenue Market Share (%) Forecast by Type in 2022 94
  • Table Global Irritable Bowel Syndrome Revenue Forecast by Application (2017-2022) 94
  • Table Global Irritable Bowel Syndrome Revenue Share Forecast by Application (2017-2022) 94
  • Figure Global Irritable Bowel Syndrome Sales Forecast by Application (2017-2022) 95
  • Figure Global Irritable Bowel Syndrome Sales Forecast by Application in 2022 95
Back to Top
전화 문의
F A Q